JP Morgan Chase’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,000
Closed -$7.42M 7517
2024
Q4
$7.42M Buy
+40,000
New +$7.76M ﹤0.01% 2997
2024
Q1
Sell
-7,300
Closed -$1.49M 7628
2023
Q4
$1.49M Buy
+7,300
New +$1.18M ﹤0.01% 4062
2023
Q2
Sell
-6,000
Closed -$1.4M 7114
2023
Q1
$1.4M Buy
+6,000
New +$1.52M ﹤0.01% 3802

Other funds holding INSP

JP Morgan Chase's INSP Position: Q1 2026 in Review

JP Morgan Chase increased its Inspire Medical Systems (INSP) stake by 18% in Q1 2026, buying an estimated $576K and bringing the position to 53,615 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3878.

JP Morgan Chase first reported a position in INSP in Q2 2018 and has held it in 32 quarters since. The position peaked at $157M in Q3 2024. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • JP Morgan Chase held 53,615 shares of Inspire Medical Systems worth $2.7M as of Q1 2026.
  • JP Morgan Chase bought 8,227 Inspire Medical Systems shares in Q1 2026, an estimated $576K.
  • Inspire Medical Systems made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3878 holding.
  • JP Morgan Chase first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 32 quarters since.
  • JP Morgan Chase's Inspire Medical Systems position peaked at $157M in Q3 2024.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.